Drug Type Small molecule drug |
Synonyms Icoduline, Icodulinum, CBS 113A + [1] |
Target |
Action inhibitors |
Mechanism 5-LOX inhibitors(Arachidonate 5-lipoxygenase inhibitors), COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H11ClN2OS |
InChIKeyOAQDENGCTUPZEL-UHFFFAOYSA-N |
CAS Registry110952-54-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Eye Diseases | Phase 3 | France | - | |
Eye Diseases | Phase 3 | - | - | |
Skin Diseases | Preclinical | United States | - | - |
Skin Diseases | Preclinical | Canada | - | - |